SI-BONE, Inc. (SIBN) financial statements (2021 and earlier)

Company profile

Business Address 471 EL CAMINO REAL, SUITE 101
SANTA CLARA, CA 95050
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:9325
Cash and cash equivalents1025
Short-term investments81 
Other undisclosed cash, cash equivalents, and short-term investments1 
Receivables128
Inventory, net of allowances, customer advances and progress billings53
Inventory53
Deferred costs0 
Other undisclosed current assets199
Total current assets:111136
Noncurrent Assets
Property, plant and equipment42
Long-term investments and receivables1 
Long-term investments1 
Other noncurrent assets00
Total noncurrent assets:62
TOTAL ASSETS:117139
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities149
Accounts payable32
Accrued liabilities127
Debt4 
Total current liabilities:199
Noncurrent Liabilities
Long-term debt and lease obligation3539
Long-term debt, excluding current maturities3539
Liabilities, other than long-term debt00
Other liabilities00
Total noncurrent liabilities:3539
Total liabilities:5448
Stockholders' equity
Stockholders' equity attributable to parent6390
Common stock00
Additional paid in capital258247
Accumulated other comprehensive income00
Accumulated deficit(196)(157)
Total stockholders' equity:6390
TOTAL LIABILITIES AND EQUITY:117139

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Revenues6755
Cost of revenue
(Cost of Goods and Services Sold)
(7)(5)
Gross profit:6151
Operating expenses(97)(63)
Operating loss:(36)(12)
Nonoperating income (expense)3(0)
Investment income, nonoperating31
Other nonoperating expense(0)(1)
Interest and debt expense(5)(5)
Loss from continuing operations before income taxes:(38)(17)
Income tax expense(10)(5)
Net loss:(48)(22)
Other undisclosed net income attributable to parent105
Net loss available to common stockholders, diluted:(38)(17)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(48)(22)
Comprehensive loss:(48)(22)
Other undisclosed comprehensive income, net of tax, attributable to parent105
Comprehensive loss, net of tax, attributable to parent:(38)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: